Charity Breast Cancer Now has described the failure to negotiate a fair price of Enhertu as “utterly heartbreaking”.
When it comes to neurodegenerative conditions such as Alzheimer’s, Parkinson’s and Huntington ... to receiving Orphan ...
In this Science segment, we examine the European Medicines Agency's recent decision to recommend granting marketing authorization for the anti-Alzheimer's drug lecanemab. This follows an earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback